drugset / Trial / NCT06340984

Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast

NCT06340984

Phase 3 Unknown 60 enrolled South Valley University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to: 1. Evaluation of serum soluble intercellular adhesion molecule-1 (sICAM-1) level in acne vulgaris and compare it to control group 2. Evaluate its role in acne pathogenesis and its correlation with acne vulgaris severity 3. Evaluate the effect of Montelukast on serum (sICAM-1) level in acne vulgaris

Timeline

Start
2024-06
Primary completion
2024-11
Completion
2025-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral

Indications